Literature DB >> 27511738

Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome.

Baptiste Hervier1, Mikaël Perez2, Yves Allenbach3, Hervé Devilliers4, Fleur Cohen5, Yurdagül Uzunhan6, Hanane Ouakrim7, Karim Dorgham8, Jean-François Méritet9, Elisabeth Longchampt10, Werner Stenzel11, Isabelle Cremer2, Olivier Benveniste12, Vincent Vieillard8.   

Abstract

Antisynthetase syndrome (aSS) is characterized by the association of interstitial lung disease and myositis with anti-tRNA synthetase autoantibodies. Immune mechanisms leading to aSS could be initiated in the lungs, but the role of NK cells has not yet been studied. Both extensive NK cell phenotype and functions were compared between 33 patients and 26 controls. Direct and redirected polyfunctionality assays (degranulation and intracellular production of TNF-α and IFN-γ) were performed spontaneously or after IL-12 plus IL-18 stimulation in the presence of K562 or P815 target cells, respectively. NK cells from inactive patients showed normal phenotype, whereas active aSS revealed a differentiated NK cell profile, as indicated by increased CD57 and Ig-like transcript 2 and an inability to produce IFN-γ (p = 0.002) compared with controls. Importantly, active aSS was more specifically associated with a significant NKp30 decrease (p = 0.009), although levels of mRNA and intracellular protein were similar in aSS and healthy controls. This NKp30 decrease was strongly correlated with reduced NK cell polyfunctionality in both direct and redirected killing assays with anti-NKp30 Abs (p = 0.009 and p = 0.03, respectively), confirming its important impact in aSS. Histological studies revealed massive infiltrations of NK cells inside the lungs of aSS patients (148 versus 11/mm(2)). Taken together, these data suggest that NK cells and NKp30 could play a role in aSS pathogenesis.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27511738     DOI: 10.4049/jimmunol.1501902

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Inflammatory myopathies: NK cell function linked to antisynthetase syndrome.

Authors:  Joanna Collison
Journal:  Nat Rev Rheumatol       Date:  2016-08-25       Impact factor: 20.543

Review 2.  Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management.

Authors:  Elena De Zorzi; Paolo Spagnolo; Elisabetta Cocconcelli; Elisabetta Balestro; Luca Iaccarino; Mariele Gatto; Francesco Benvenuti; Nicol Bernardinello; Andrea Doria; Toby M Maher; Elisabetta Zanatta
Journal:  Clin Rev Allergy Immunol       Date:  2022-03-18       Impact factor: 10.817

3.  Persistence of dysfunctional natural killer cells in adults with high-functioning autism spectrum disorders: stigma/consequence of unresolved early infectious events?

Authors:  Meriem Bennabi; Nadine Tarantino; Marion Leboyer; Ryad Tamouza; Vincent Vieillard; Alexandru Gaman; Isabelle Scheid; Rajagopal Krishnamoorthy; Patrice Debré; Arthur Bouleau; Mireille Caralp; Sonia Gueguen; Myriam Ly Le-Moal; Manuel Bouvard; Anouck Amestoy; Richard Delorme
Journal:  Mol Autism       Date:  2019-05-15       Impact factor: 7.509

Review 4.  NK Cells in the Human Lungs.

Authors:  Baptiste Hervier; Jules Russick; Isabelle Cremer; Vincent Vieillard
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

5.  Distinct interferon signatures stratify inflammatory and dysimmune myopathies.

Authors:  Muriel Rigolet; Cyrielle Hou; Yasmine Baba Amer; Jessie Aouizerate; Baptiste Periou; Romain K Gherardi; Peggy Lafuste; François Jérôme Authier
Journal:  RMD Open       Date:  2019-02-26

6.  Iacta Alea Est: The Inexorable Advance of Tofacitinib in the Treatment of Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. A Case Report.

Authors:  Walter Conca; Ihab Weheba; Mohei-Eldin Abouzied; Abeer Abdelsayed; Yousif Aleyouni; Eid Al-Mutairy; Nasir Bakshi; Mohammad Khalid
Journal:  Front Pharmacol       Date:  2020-12-15       Impact factor: 5.810

Review 7.  Natural killer cells in inflammatory autoimmune diseases.

Authors:  Yuyan Yang; Jessica Day; Fernando Souza-Fonseca Guimaraes; Ian P Wicks; Cynthia Louis
Journal:  Clin Transl Immunology       Date:  2021-02-01

8.  NK Cell Patterns in Idiopathic Inflammatory Myopathies with Pulmonary Affection.

Authors:  Marc Pawlitzki; Christopher Nelke; Leoni Rolfes; Rebecca Hasseli; Stylianos Tomaras; Eugen Feist; Anne Schänzer; Saskia Räuber; Liesa Regner; Corinna Preuße; Yves Allenbach; Olivier Benveniste; Heinz Wiendl; Werner Stenzel; Sven G Meuth; Tobias Ruck
Journal:  Cells       Date:  2021-09-27       Impact factor: 6.600

9.  Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses.

Authors:  Ryan A Adams; Cátia Fernandes-Cerqueira; Antonella Notarnicola; Elisabeth Mertsching; Zhiwen Xu; Wing-Sze Lo; Kathleen Ogilvie; Kyle P Chiang; Jeanette Ampudia; Sanna Rosengren; Andrea Cubitt; David J King; John D Mendlein; Xiang-Lei Yang; Leslie A Nangle; Ingrid E Lundberg; Per-Johan Jakobsson; Paul Schimmel
Journal:  Cell Mol Immunol       Date:  2019-12-04       Impact factor: 11.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.